Low dose of L-arginine does not change endothelial permeability of aorta and coronary arteries in rat

Pakistan Journal of Nutrition

Volumn 7, Issue 1, 2008, Pages 126-129

  Nematbakhsh, Mehdi ^a   Heydarzadeh, Zahra ^a   Borjian, Lila ^a   Haghjooyejavanmard, Shaghayegh ^a  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Aorta; Blood pressure; Coronary artery; Endothelial permeability; L arginine; Nitric oxide

Indexed keywords

ARGININE; NITRIC OXIDE; NITRIC OXIDE DONOR; NITRITE;

ANIMAL TISSUE; AORTA; ARTERY ENDOTHELIUM; ARTICLE; BLOOD LEVEL; BLOOD PRESSURE MEASUREMENT; CONTROLLED STUDY; CORONARY ARTERY; DIASTOLIC BLOOD PRESSURE; LOW DRUG DOSE; MALE; MEAN ARTERIAL PRESSURE; MEMBRANE PERMEABILITY; METABOLITE; NONHUMAN; RAT; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE;

RATTUS;

EID: 37549030521     PISSN: 16805194     EISSN: None     Source Type: Journal    
DOI: 10.3923/pjn.2008.126.129     Document Type: Article

References (38)

1. Addicks, K., S. Arnhold, P. Fasching, C. Hoffmann and W. Bloch, 1995. Nitric oxide mediates microvascular permeability in the isolated perfused rat mesentery? Agents Actions Suppl., 45: 139-44.
2. Anderson, T.J., 1999. Assessment and treatment of endothelial dysfunction in humans. J. Am. Coll. Cardiol., 34: 631-8.
3. Artigues, C., V. Richard, C. Roussel, F. Lallemand, J.P. Henry and C. Thuillez, 2000. Increased endothelium-monocyte interactions in salt-sensitive hypertension: effect of L-arginine. J. Cardiovasc Pharmacol., 35: 468-73.
4. Baldwin, A.L., G. Thurston ard H. al Naemi, 1998. Inhibition of nitric oxide synthesis increases venular permeability and alters endothelial actin cytoskeleton. Am. J. Physiol., 274: H1776-84.
5. Boger, R.H., S.M. Bode-Boger, R.P. Brandes, L. Phivthong-ngam, M. Bohme and R. Nafe, 1997. Dietary L-arginine reduces the progression of atherosclerosis in cholesterol-fed rabbits: comparison with lovastatin. Circulation, 96: 1282-1290.
6. Cines, D., E. Pollak and Buckc, 1998. Endothelial in physiology and in phathophysiology of vascular disorder. Blood, 91: 3527-3561.
7. Chen, J., P. Kuhlencordt, F. Urano, H. Ichinose, J. Astern and P.L. Huang, 2003. Effects of chronic treatment with L-arginine on atherosclerosis in apoE knockout and apoE/inducible NO synthase double-knockout mice.Arterioscler Thromb Vasc Biol., 23: 97-103.
8. Cooke, J.P. and P.S. Tsao, 1997. Arginine: a new therapy for atherosclerosis? Circulation, 95: 311-312.
9. DE Fatima Cavanal, M., G.N. Gomes, A.L. Forti, S.O. Rocha, M.D. Franco, Z.B. Fortes and F.Z. Gil, 2007. The Influence of I-Arginine on Blood Pressure, Vascular Nitric Oxide and Renal Morphometry in the Offspring from Diabetic Mothers. Pediatr. Res., 62: 145-150.
10. Filep, J.G., E. Földes-Filep and P. Sirois, 1993. Nitric oxide modulates vascular permeability in the rat coronary circulation. Br. J. Pharmacol., 108: 323-6.
11. Galley, H.F. and N.R. Webster, 2004. Physiology of the endothelium. BRJA., 93: 105-13.
12. Gokce, N., 2004. L-arginine and hypertension. J. Nutr., 134: 2807S-2811S; discussion 2818S-2819S.
13. Gornik, H.L. and M.A. Creager, 2004. Arginine and endothelial and vascular health. J. Nutr., 134: 2880S-2887S.
14. Gouvea, S.A., M.R. Moyses, N.S. Bissoli, J.G. Pires, A.M. Cabral and G.R. Abreu, 2003. Oral administration of L-arginine decreases blood pressure and increases renal excretion of sodium and water in renovascular hypertensive rats. Braz. J. Med. Biol. Res., 36: 943-9.
15. Hansen, P.R. and S. Haunso, 1995. Effects of nitric oxide synthase inhibition on myocardial capillary permeability and reactive hyperaemic response. Cardiovasc Res., 29: 862-6.
16. Hayashi, T., P.A. Juliet, H. Matsui-Hirai, A. Miyazaki, A. Fukatsu and J. Funami, 2005. I-Citrulline and I-arginine supplementation retards the progression of high-cholesterol-diet-induced atherosclerosis in rabbits. Proc. Natl. Acad. Sci. USA, 102: 13681-13686.
17. Hinder, F., M. Booke, L.D. Traber and D.L. Traber, 1997. Nitric oxide and endothelial permeability. J. Appl. Physiol., 83: 1941-6.
18. Hulthen, U.L., Z. Cao, J.R. Rumble, M.E. Cooper and C.I. Johnston, 1996. Vascular hypertrophy and albumin permeability in a rat model combining hypertension and diabetes mellitus. Effects of calcium antagonism, angiotensin converting enzyme inhibition and angiotensin II-AT1-receptor blockade. Am. J. Hypertens., 9: 895-901.
19. Jeremy, R.W., H. McCarron and D. Sullivan, 1996. Effects of dietary L-arginine on atherosclerosis and endothelium-dependent vasodilatation in the hypercholesterolemic rabbit. Response according to treatment duration, anatomic site and sex. Circulation., 94: 498-506.
20. Kojda, G., K. Kottenberg and E. Noack, 1997. E. Inhibition of nitric oxide synthase and soluble guanylate cyclase induces cardiodepressive effects in normal rat hearts. Eu. J. Pharmacol., 334: 181-90.
21. Kubes, P., 1993. Nitric oxide-induced microvascular permeability alterations: a regulatory role for cGMP. Am. J. Physiol., 265: H1909-15.
22. Loscalzo, J., 2003. Adverse effects of supplemental L-arginine in atherosclerosis: consequences of methylation stress in a complex catabolism? Arterioscler Thromb. Vasc. Biol., 23: 3-5.
23. Lundblad, C. and P. Bentzer, 2007. Effects of L-arginine on cerebral blood flow, microvascular permeability, number of perfused capillaries and brain water content in the traumatized mouse brain Microvasc Res., 74: 1-8.
24. Luscher, T. and M. Barton, 1997. Biology of the endothelium. Clin. Cardiol., 20: s3-s10.
25. Mayhan, W.G., 1993. Role of nitric oxide in leukotriene C4-induced increases in microvascular transport. Am. J. Physiol., 265: H409-14.
26. Megson, I.L. and D.J. Webb, 2002. Nitric oxide donor drugs: current status and future trends. Expert Opin. Investig. Drugs, 11: 587-601.
27. Motlekar, N.A., K.S. Srivenugopal, M.S. Wachtel and B.B. Youan, 2006. Modulation of gastrointestinal permeability of low-molecular-weight heparin by L-arginine: in-vivo and in-vitro evaluation. J. Pharm. Pharmacol., 58: 591-8.
28. Napoli, C., F. de Nigris, S. Williams-Ignarro, O. Pignalosa, V. Sica and L.J. Ignarro, 2006. Nitric oxide and atherosclerosis: an update. Nitric Oxide, 15: 265-279.
29. Nematbakhsh, M., P. Hayat-Davoodi, P. Rajabi and S.H. Samarian, 2002. The effect of estrogen on endothelial permeability of aorta and the level of serum nitrite concentration in cholesterol-fed ovariectomized rabbit. Iran Biomedical. J., 6: 77-82.
30. Ohta, F., T. Takagi, H. Sato and L.J. Ignarro, 2007. Low-dose L-arginine administration increases microperfusion of hindlimb muscle without affecting blood pressure in rats. Proc. Natl. Acad Sci. USA, 23: 1407-11
31. Palloshi, A., G. Fragasso, P. Piatti, L.D. Monti, E. Setola, G. Valsecchi, E. Galluccio, S.L. Chierchia and A. Margonato, 2004. Effect of oral L-arginine on blood pressure and symptoms and endothelial function in patients with systemic hypertension, positive exercise tests and normal coronary arteries. Am. J. Cardiol., 93: 933-5.
32. Penttinen, J., J. Toyry, S. Eerikainen, H. Litmanen, T. Rinkinen and E. Lansimies, 1998. Does plasma L-arginine level play a role in regulation of blood pressure during exercise and autonomic nervous function? Clin. Physiol., 18: 539-43.
33. Radomski, M.W. and E. Salas, 1995. Nitric oxide-biological mediator, modulator and factor of injury: its role in the pathogenesis of atherosclerosis. Atherosclerosis, 118 Suppl: S69-80. Review.
34. Rumbaut, R.E. and V.H. Huxley, 2002. Similar permeability reiponses to nitric oxide synthase inhibitors of venules from three animal species. Microvasc Res., 64: 21-31.
35. Shimamura, K., M. Zhou, M. Toba, S. Kimura, T. Higuchi, H. Kawaguchi, F. Sekiguchi and S. Sunano, 2003. Effects of L-arginine on spontaneous contraction of the rat portal vein. Pflugers Arch., 446: 30-5.
36. St-Pierre, P., L. Bouffard and P. Maheux, 2004. Rosiglitazone increases extravasation of macromolecules and endothelial nitric oxide synthase in skeletal muscles of the fructose-fed rat model. Biochem. Pharmacol., 67: 1997-2004.
37. Susic, D., J. Varagic and E.D. Frohlich, 2001. Isolated systolic hypertension in elderly WKY is reversed with L-arginine and ACE inhibition. Hypertension., 38: 1422-6.
38. van Nieuw Arnerongen, G.P. and V.W. van Hinsbergh, 2002. Targets for pharmacological intervention of endothelial hyperpermeability and barrier function. Vascul Pharmacol., 39: 257-72.